Mead Johnson, which had originally filed in mid-September, lodged a new application for an IPO with the SEC on Thursday. A leading provider of infant formula and other pediatric nutrition products, the company generated net sales of $2.8 billion in the twelve months ending September 30, 2008. While the company has not yet announced terms, the company's fairly defensive business model and leading industry position should create some investor interest in the deal. Citi and Morgan Stanley are set to be the joint book runners on the deal.
